Evidence map›Paper›PMID 30620010›Full record

ArticleLife science alliance2019

Mechanistic aspects of maltotriose-conjugate translocation to the Gram-negative bacteria cytoplasm.

Estelle Dumont, Julia Vergalli, Jelena Pajovic, Satya P Bhamidimarri, Koldo Morante, Jiajun Wang, Dmitrijs Lubriks, Edgars Suna, Robert A Stavenger, Mathias Winterhalter and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Mechanism of Resistance Development inPharmaceuticals (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 6 countries.

Estelle DumontAix Marseille Univ, Institut National de la Santé et de la Recherche Médicale, Service de Santé des Armées, Institut de Recherche Biomédicale des Armées, Membranes et Cibles Thérapeutiques, Marseille, France.
Julia VergalliAix Marseille Univ, Institut National de la Santé et de la Recherche Médicale, Service de Santé des Armées, Institut de Recherche Biomédicale des Armées, Membranes et Cibles Thérapeutiques, Marseille, France.
Jelena PajovicDISCO Beamline, Synchrotron Soleil, Saint-Aubin, France.
Satya P BhamidimarriDepartment of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany.
Koldo MoranteDepartment of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany.ORCID 0000-0002-9877-9168
Jiajun WangDepartment of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany.
Dmitrijs LubriksLatvian Institute of Organic Synthesis, Riga, Latvia.
Edgars SunaLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0002-3078-0576
Robert A StavengerAntibacterial Discovery Performance Unit, Infectious Diseases Discovery, GlaxoSmithKline, Collegeville, PA, USA.
Mathias WinterhalterDepartment of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany.
Matthieu RéfrégiersDISCO Beamline, Synchrotron Soleil, Saint-Aubin, France.ORCID 0000-0002-3281-2308
Jean-Marie PagèsAix Marseille Univ, Institut National de la Santé et de la Recherche Médicale, Service de Santé des Armées, Institut de Recherche Biomédicale des Armées, Membranes et Cibles Thérapeutiques, Marseille, France.ORCID 0000-0001-7092-7977
Constructor University · DEInstitut de Médecine Tropicale du Service de Santé des Armées · FRLatvijas Organiskās Sintēzes Institūts · LVSynchrotron soleil · FRGlaxoSmithKline (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small molecule accumulation in Gram-negative bacteria is a key challenge to discover novel antibiotics, because of their two membranes and efflux pumps expelling toxic molecules. An approach to overcome this challenge is to hijack uptake pathways so that bacterial transporters shuttle the antibiotic to the cytoplasm. Here, we have characterized maltodextrin-fluorophore conjugates that can pass through both the outer and inner membranes mediated by components of the

Indexed as

Bacterial Outer Membrane ProteinsCell Membrane PermeabilityCytoplasmDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli ProteinsGene Knockout TechniquesMaltoseMaltose-Binding ProteinsMembrane Transport ProteinsOligosaccharidesOperonPeriplasmPeriplasmic Binding ProteinsPerylenePolysaccharidesBacterial Outer Membrane ProteinsEscherichia coli ProteinsMalE protein, E colimaltodextrinmaltohexaosemaltoporinsMaltoseMaltose-Binding ProteinsmaltotrioseMembrane Transport ProteinsOligosaccharidesPeriplasmic Binding ProteinsPerylenePolysaccharidesPorinsReceptors, VirusTrisaccharides

Identifiers

PMID30620010
PMCPMC6311466
OpenAlexW2906714628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.